Demand Grows For Proton Therapy Equipment Amid Calls For More Research
This article was originally published in The Gray Sheet
Executive Summary
Burgeoning clinical adoption of resource-intensive proton radiation therapy for cancer creates unique challenges for payers, manufacturers, health care providers and patients, stakeholders say
You may also be interested in...
Radiation Oncologists Question Double-Digit Cuts To Medicare Physician Payments
In its draft 2013 physician fee schedule issued July 6, CMS proposes an overall 14% decrease in reimbursement rates for radiation oncology therapy services based on new assumptions for intensity modulated radiation therapy and stereotactic body radiation therapy procedure times.
ECRI Institute Offers Medical Technology Recommendations To Hospitals
ECRI Institute recommends 10 technology-related issues for hospitals to consider in their 2012 decision-making.
Evidence Lacking On Proton Therapy For Non-Small-Cell Lung Cancer – BCBS
Blue Cross Blue Shield’s Technology Evaluation Center found there is insufficient evidence that proton beam therapy improves health outcomes for patients with non-small-cell lung cancer.